Moreover, by cross-validation of tumoral general highly expressed marker CD44 and CK19 in patient- and mouse-derived tissue samples, we could confirm the integrity of newly generated HCC cell lines. This evidence concerns the gene KRT19 and hepatocellular carcinoma.